SINCO PHARMA 06833Hong Kong Stock Exchange

0.1380.73%( +0.001 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
SINCO PHARMA (06833) Company Profile - Company Info, Industry & Management - cibo
返回 Overview News Financials Shareholders Profile IPO ›

Company Information

Market
HKEX Main Board
Listing Date
2016-03-10
Industry
Pharmaceutical Distribution
Fiscal Year End
Dec 31
ISIN
KYG8154Y1052

Industry

Pharmaceutical Distribution 0.24%
20 stocks in this industry
Down 5 Up 11
Industry RankingsValue (HKD)Rank
Revenue (Last FY)2.44B9/19
Net Profit (Last FY)40.87M9/19
ROE (Last FY)5.02%10/19

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Huang Zhijian Executive Director
Lei Shifeng Executive Director
Jing Huan Non-Executive Director
Bai Zhizhong Independent Non-Executive Director
Lau Ying Kit Independent Non-Executive Director
Wang Qing Independent Non-Executive Director
Liu Wenfang Independent Non-Executive Director
Dong Yingjie Independent Non-Executive Director
Ye Guowei Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-28.

About this page

This page shows SINCO PHARMA (06833) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

© 2026 cibo｜Terms of ServicePrivacy PolicyDisclaimer